Compugen Ltd (NAS:CGEN)
$ 1.57 -0.06 (-3.68%) Market Cap: 141.45 Mil Enterprise Value: 31.69 Mil PE Ratio: 52.62 PB Ratio: 2.33 GF Score: 53/100

Compugen Ltd at Stifel Virtual Healthcare Conference Transcript

Nov 17, 2020 / 01:40PM GMT
Release Date Price: $13.55 (+0.37%)
Stephen Willey
Stifel Nicolaus - Analyst

Good morning, everyone. I am Stephen Willey, one of the senior biotech analysts here at Stifel. I appreciate everyone's attendance at the 2020 virtual healthcare conference.

With us this morning from Compugen we have a number of senior executives participating in the discussion we're going to have today -- Anat Cohen-Dayag, who is the Chief Executive Officer; Ari Krashin, who is the CFO; Eran Ophir, who is the Chief Medical Officer and -- or Chief Scientific Officer, I'm sorry; and then Henry Adewoye, who just joined us is the Chief Medical Officer. So Anat, I don't know if you want to kind of make any opening statements before we get into Q&A just with respect to who you are, what you do.

Anat Cohen;Dayag
Compugen Ltd. - President & CEO

Sure. We are a therapeutic discovery and development company. We discover new drug targets and new biological pathways and we develop first-in-class drugs in order to address these drug targets. And the way we discover new drug targets is by a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot